Bio Integrates 2021 Track 2


2020 was an unprecedented year. What impact has it had on biotech funding, pipelines and ecosystem?

Welcome and opening remarks

Andy Richards

A fireside chat with Ian McCubbin

Interview conducted by Martino Picardo, Chairman, Discovery Park

A fireside chat with Eliot Forster

Interview conducted by Martino Picardo, Chairman, Discovery Park

Never let a crisis go to waste

Raising investment and meeting milestones is difficult enough in normal times. We hear from those who have thrived through the pandemic.


ZAHID MONEER | Managing Director Healthcare Investment Banking | BNP Paribas


JOLYON MARTIN | Founder and Business Development | PetMedix
EDDIE BLAIR | Chairman | Virokine Therapeutics
JASON MELLAD | Chief Executive Officer | Start Codon
DAVID ATKINS | Chief Executive Officer | Congenica
HEATHER FAIRHEAD | Founder & Chief Executive Officer | Phico Therapeutics

The Global Biopharma Resilience Index

Cytiva’s Global Biopharma Resilience Index – based on a survey of more than 1,000 senior biopharma executives – takes a holistic look at the industry across five key pillars at a time when its health is vital. Fresh data shows there is work to be done to secure its future.

EMMANUEL LIGNER | President and Chief Executive Officer | Cytiva

It’s about time

COVID-19 vaccines have shown the public just how fast we can develop, assess and approve medicines. How can we accelerate these timelines outside of a pandemic?


IAN MUIR | Chief Executive Officer | Porton Biopharma


PAUL STOTT | Chief Executive Officer | Seda Pharmaceutical Development Services
JILL RECKLESS | Chief Executive Officer | RxCelerate
FLIC GABBAY | Managing Partner | tranScrip
SANDY DOUGLAS | Research Group Leader | The University of Oxford
NICK SMITH | Associate Director of Operations | Cobra Biologics

Should I stay or should I go?

Brexit and the imminent funding gap has led to companies looking to locate elsewhere. We hear from countries/regions trying to attract Life Science companies.


KATH MACKAY | Managing Director | Bruntwood SciTech – Alderley Park


PATRICK DRISCOLL | Chief Financial Officer | CN Bio Innovations
WILL BROOKS | Investment Director | Downing
ADRIAN HILL | HealthTec Development Manager | UKRI – STFC, Harwell Campus
MAYER SCHREIBER | Chief Executive Officer | Discovery Park
RORY MAW | Director | The Oxford Science Park

Leading Change into a new world

Faced with ongoing change what have we learnt that will serve us well as we lead in 2021 and beyond…

• Why will leading change continue to be important in 2021 and beyond?
• How can we reset and reenergize?
• What are the key success factors in leading change?


KATHRYN SIMPSON | Business Consultant | Kathryn Simpson Consulting


JOHN POTTAGE | Former Senior Vice President, Chief Scientific and Medical Officer | ViiV Healthcare
BRUCE CLARK | Past President and Chief Executive Officer | Medicago Inc
TOBY REID | Chief Executive Officer | BioCity Group
PRIYA MANDE | Chief Operating Officer | PsiOxus Therapeutics
JOANNA GOULD | Chief Executive Officer and Co-founder | VisusNano

Next in the series…..

£1m – £5m is the new funding valley of death. How do you effectively position your business for Series A funds, and how do you select investors that are right for you?


JANE DANCER | Independent Consultant


AMIT SHAH | Biotech Venture Capital Investor | S.R. One Ltd
CATHERINE PICKERING | Chief Executive Officer and co-founder | iOnctura
HAKAN GOKER | Vice President | M Ventures
CHARLOTTE CASEBOURNE | Co-Founder & Chief Executive Officer | Theolytic
Nanosyrinx | speaker to be confirmed